Categories: News

Afya Limited to Report Fourth Quarter 2020 and 2020 Unaudited Financial Results on April 8

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

NOVA LIMA, Brazil and MINAS GERAIS, Brazil, March 24, 2021 (GLOBE NEWSWIRE) — Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report fourth quarter 2020 and 2020 unaudited financial results for the period ended December 31, 2020, following the close of the market on Thursday, April 8th, 2021.

The Company will host a corresponding conference call and webcast on April 9 at 10:00 AM EDT.

More details about the call will be available in the week of the event.

A live and archived webcast of the call will be available on the Investor Relations section of the Company’s website at https://ir.afya.com.br/.

About Afya Limited (Nasdaq: AFYA)

Afya is a leading medical education group in Brazil based on number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students and physicians to transform their ambitions into rewarding lifelong experiences from the moment they join us as medical students through their medical residency preparation, graduation program, continuing medical education activities and their daily practices with digital products

Investor Relations Contact:

Afya Limited

ir@afya.com.br

Source: Afya Limited

Staff

Recent Posts

LabConnect Selects Deloitte to Streamline Financial and Business Operations

JOHNSON CITY, Tenn., June 12, 2025 /PRNewswire/ -- LabConnect, a leading provider of global central…

3 hours ago

BUDS Technology Transforms Senior Care with AKSSI Virtual Nurse Assistant

ROSWELL, Ga., June 12, 2025 /PRNewswire/ -- Buds Technology, a leading innovator in healthcare solutions, has…

3 hours ago

Amendola Earns Three Prestigious Healthcare and Health Tech-Focused PR Awards

SCOTTSDALE, Ariz., June 12, 2025 /PRNewswire/ -- Amendola, an award-winning, insights-driven public relations and marketing…

3 hours ago

Vascarta Receives FDA Orphan Drug Designation for Vasceptor® in the Treatment of Sickle Cell Disease

SUMMIT, N.J., June 12, 2025 /PRNewswire/ -- Vascarta Inc., a biopharmaceutical company committed to advancing…

3 hours ago

Enjoin Earns 2025 Great Place To Work Certification™

The mid-revenue cycle solutions provider announces prestigious award for second consecutive year. NASHVILLE, Tenn., June…

3 hours ago

Hospital Leaders to Speak at HFMA 2025 Conference on Successful Use of AI in Utilization Management

Experts from Stormont Vail Health will share achievements using MCG artificial intelligence to improve hospital…

3 hours ago